DeepChek® NGS ecosystem maps viral resistance mutations to next-generation therapies, unlocking new insights for ...
ABL Diagnostics accelerates international growth with key public contracts and platform-agnostic microbiology solutions ...
ABL Bio starts US phase 1 dosing for two bispecific ADCs Neok Bio begins U.S. phase 1 trials of dual-target ADCs ABL206 and ...
ABL Diagnostics (Euronext Paris – FR001400AHX6), a company specialized in molecular diagnostics for infectious diseases, announces that its Board of Directors, at its meeting held on April 30, 2026, ...
NEOK Bio came out of stealth in spring 2025 with $75 million in funding from Korean parent ABL Bio. Peninsula company to take ...
ABL DIAGNOSTICS (ISIN: FR001400AHX6 - Ticker: ABLD-FR), a leading company in molecular diagnostics and genotyping, announces the publication of a new research note (flash note) by Allinvest (Invest ...
ABL Bio tumbled 19.28% on the Kosdaq after news broke that its drug candidate had failed to meet some key endpoints in a ...
Get all latest & breaking news on Abl Biotechnologies. Watch videos, top stories and articles on Abl Biotechnologies at ...
1mon
Abl Biotech
Get all latest & breaking news on Abl Biotech. Watch videos, top stories and articles on Abl Biotech at moneycontrol.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results